The Nuclear Orphan Receptor NR2F6 Is a Central Checkpoint for Cancer Immune Surveillance
Nuclear receptor subfamily 2, group F, member 6 (NR2F6) is an orphan member of the nuclear receptor superfamily. Here, we show that genetic ablation of Nr2f6 significantly improves survival in the murine transgenic TRAMP prostate cancer model. Furthermore, Nr2f6−/− mice spontaneously reject implante...
Main Authors: | Natascha Hermann-Kleiter, Victoria Klepsch, Stephanie Wallner, Kerstin Siegmund, Sebastian Klepsch, Selma Tuzlak, Andreas Villunger, Sandra Kaminski, Christa Pfeifhofer-Obermair, Thomas Gruber, Dominik Wolf, Gottfried Baier |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-09-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124715009201 |
Similar Items
-
Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
by: Victoria Klepsch, et al.
Published: (2020-01-01) -
Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6
by: Victoria Klepsch, et al.
Published: (2021-05-01) -
Loss of the orphan nuclear receptor NR2F6 enhances CD8+ T-cell memory via IFN-γ
by: Bojana Jakic, et al.
Published: (2021-02-01) -
Orphan Nuclear Receptor NR2F6 Suppresses T Follicular Helper Cell Accumulation through Regulation of IL-21
by: William J. Olson, et al.
Published: (2019-09-01) -
Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade
by: Victoria Klepsch, et al.
Published: (2018-04-01)